Article Sidebar
Views pdf: 46
RESULTS AND PREDICTORS OF GOOD OUTCOME AFTER THROMBECTOMY FOR ISOLATED M2 OCCLUSION: DATA FROM A STROKE CENTER IN VIETNAM
Main Article Content
Abstract
Background and aims: Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) with medium-size vessel occlusions is a matter of controversy. This study aimed to find out the predictors of favorable outcomes 3 months after MT for acute ischemic stroke patients with isolated M2 occlusions at Bach Mai Stroke Center (BMSC). Methods: A cross-sectional retrospective study was conducted at BMSC from January 2021 to May 2022. The AIS patients due to M2 occlusion treated with mechanical thrombectomy with or without intravenous thrombolysis were recruited. The primary endpoint was the rate of favorable outcomes (defined as mRS 0-2). Multivariate regression analysis was performed to find out the predictors of favorable outcomes after 3 months. Results: 52 patients were recruited (males 48.1%; median age 68 (60-76)). The baseline NIHSS and ASPECTS scores were 12 (9-15), and 7 (6-8), respectively. The bridging therapy was applied in 14 (26.9%) patients. After 3 months, 31 (59.6%) patients got favorable outcomes (mRS 0-2). The multivariate regression model revealed that a successful recanalization (mTICI 2b-3) independently related to a 90th-day good outcome (OR=51.33; 95% CI: 3.81-691.02; p=0.003). Conclusion: In this study, a good outcome was observed in 59.6% of AIS patients due to M2 occlusion receiving thrombectomy therapy. A successful recanalization (mTICI 2b-3) was the independent predictor of a favorable outcome after 3 months.
Article Details
Keywords
Predictors, Acute ischemic stroke patients due to M2 occlusion, mechanical thrombectomy.
References
2. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12): e344-e418. doi:10.1161/ STR.0000000000000211
3. Xu Y, Fu W, Wang Y, Bi Q, Wang Q, Yang L, Zhang Q and Wang F (2023). Endovascular treatment for acute M2 occlusion stroke within 6 hours-a retrospective real-world evidence. Front. Cardiovasc. Med. 9:1063078. doi: 10.3389/fcvm. 2022.1063078.
4. Chamorro Á, Blasco J, López A, et al. Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients. Sci Rep. 2017;7:11636. doi:10.1038/s41598-017-11946-y
5. Von Kummer R, Broderick JP, Campbell BCV, et al. The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. Stroke. 2015; 46(10): 2981-2986. doi:10.1161/STROKEAHA. 115.010049
6. Menon BK, Hill MD, Davalos A, Roos YBWEM, Campbell BCV, Dippel DWJ, Guillemin F, Saver JL, van der Lugt A, Demchuk AM, Muir K, Brown S, Jovin T, Mitchell P, White P, Bracard S, Goyal M. Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration. J Neurointerv Surg. 2019 Nov;11(11):1065-1069. doi: 10.1136/neurintsurg-2018-014678. Epub 2019 Apr 11.
7. Khan M, Goddeau RP Jr, Zhang J, Moonis M, Henninger N. Predictors of Outcome following Stroke due to Isolated M2 Occlusions. Cerebrovasc Dis Extra. 2014 Mar 7;4(1):52-60. doi: 10.1159/000360075.
8. Kniep H, Meyer L, Broocks G, Bechstein M, Guerreiro H, Winkelmeier L, Brekenfeld C, Flottmann F, Deb-Chatterji M, Alegiani A, Hanning U, Thomalla G, Fiehler J, Gellißen S; German Stroke Registry – Endovascular Treatment (GSR – ET). Predictors of functional outcome after thrombectomy for M2 occlusions: a large scale experience from clinical practice. Sci Rep. 2023 Oct 31;13(1):18740.